Substances · Arylcyclohexylamines
O-DSMT (O-Desmethyltramadol)
- Preferred name
- O-DSMT (O-Desmethyltramadol)
- IUPAC name
- 3-[(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol
- Parent CAS number (reference)
- 80456-81-1
- Molecular formula
- C15H23NO2
- Molecular weight
- 249.35 g/mol
- InChIKey
- UWJUQVWARXYRCG-HIFRSBDPSA-N
- PubChem
- CID 9838803
- Source
- PubChem
- Verified synonyms & catalog abbreviations
-
O-Desmethyltramadol ODSMT O DSMT Desmetramadol
Matching Listings in This Store's Catalog
Verified Neurochemical & Toxicological Intelligence
O-DSMT (O-Desmethyltramadol)
Receptor Telemetry & Mechanism of Action
Active M1 metabolite of tramadol: (+)-O-DSMT acts as a selective mu-opioid receptor (MOR Ki = 18 nM) agonist (~200x higher MOR affinity than parent tramadol), while (−)-O-DSMT inhibits norepinephrine reuptake (NET), lacking tramadol's parent SERT bottleneck.
Biotransformation & Active Metabolites
Direct active metabolite; inactivated via UGT2B7/1A8 glucuronidation without requiring CYP2D6 activation.
Temporal Pharmacokinetics
Mu-Opioid Receptor Agonist & Norepinephrine Reuptake Inhibitor — Only opioid-class compound in our substance catalog; unlike parent tramadol, O-DSMT does not depend on CYP2D6 genetics and has minimal SERT activity, but carries full opioid respiratory depression, rapid physical dependence, and lethal interaction risk with benzodiazepines, alcohol, or GHB.
- Onset 20–45 min
- Peak Window 1.5–3.5 h
- Total Window 5–8 h
- Residual / Half-Life 4–10 h residual miosis/sedation
Only opioid-class compound in our substance catalog; unlike parent tramadol, O-DSMT does not depend on CYP2D6 genetics and has minimal SERT activity, but carries full opioid respiratory depression, rapid physical dependence, and lethal interaction risk with benzodiazepines, alcohol, or GHB.
Quantitative Response Spectrum (Published Literature)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
10–15 mg
Subtle threshold receptor activity (Mu-Opioid Receptor Agonist & Norepinephrine Reuptake Inhibitor).
Minimal baseline autonomic shift.
15–30 mg
Mild, clear-headed expression of primary class profile.
Light somatic modulation.
30–55 mg
Full characteristic neurochemical and perceptual profile documented in literature.
Moderate somatic relaxation, ataxia, or autonomic tone depending on class.
55–85 mg
Pronounced intensity, cognitive/motor impairment, or deep immersion.
Marked somatic load and heightened adverse-event sensitivity.
90+ mg
Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.
High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.
Interaction Matrix & Critical Contraindications
Critical Hazard — Never Combine
Profound synergistic respiratory depression and fatal overdose.
Unconsciousness, respiratory arrest, and fatal pulmonary aspiration.
NET inhibition plus MAOIs risks hypertensive crisis; dissociatives compound respiratory/aspiration risk.
Elevated Hazard — Avoid
Additive mu-opioid respiratory depression and unpredictable toxicity threshold.
Caution / Receptor Attenuation
Additive noradrenergic tachycardia and blood-pressure elevation.
Structural Isomer & Sibling Comparison
Only opioid-class compound in our substance catalog; unlike parent tramadol, O-DSMT does not depend on CYP2D6 genetics and has minimal SERT activity, but carries full opioid respiratory depression, rapid physical dependence, and lethal interaction risk with benzodiazepines, alcohol, or GHB.
Physicochemical Stability & Storage
Form: White to off-white crystalline analytical powder (hydrochloride salt). · Freely soluble in water and methanol.
Store dry and sealed at room temperature away from light and moisture.
Cross-Tolerance & Dependence Profile
Cross-tolerant with all mu-opioid agonists. High physical and psychological dependence liability; repeated daily exposure produces classic opioid withdrawal syndrome.
Chemical Architecture & Structural Profile
O-DSMT (O-Desmethyltramadol) (3-[(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol) is a reference compound belonging to the Arylcyclohexylamines class, characterized by the molecular formula C15H23NO2 and a molar mass of 249.35 g/mol. The parent molecule is indexed under CAS registry number 80456-81-1 and in the NCBI PubChem database as CID 9838803 (Standard InChIKey: UWJUQVWARXYRCG-HIFRSBDPSA-N).
Citations
- PubChem — PubChem (2026-11-12)
Reference Toxicology & Safety Profile
In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), O-DSMT (O-Desmethyltramadol) is indexed within the Phenylpropylamine structural group. Toxicological notes (PsychonautWiki): moderate potential toxicity relative to its dose due to its potency, potentially lethal when mixed with depressants like alcohol or benzodiazepines. Dependence liability (PsychonautWiki): moderately addictive with a high potential for abuse. Documented cross-tolerance class: opioids. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.
Citations
- PubChem — PubChem (2026-11-12)
Analytical Use & Laboratory Notice
This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.
Citations
- EUDA / National Chemical & Controlled Substance Registry (AE) — National Regulatory Authority (AE) (2026-11-12)